Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

80 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system.
Campos AC, Ortega Z, Palazuelos J, Fogaça MV, Aguiar DC, Díaz-Alonso J, Ortega-Gutiérrez S, Vázquez-Villa H, Moreira FA, Guzmán M, Galve-Roperh I, Guimarães FS. Campos AC, et al. Int J Neuropsychopharmacol. 2013 Jul;16(6):1407-19. doi: 10.1017/S1461145712001502. Epub 2013 Jan 9. Int J Neuropsychopharmacol. 2013. PMID: 23298518 Free article.
Anandamide deficiency and heightened neuropathic pain in aged mice.
Bishay P, Häussler A, Lim HY, Oertel B, Galve-Roperh I, Ferreirós N, Tegeder I. Bishay P, et al. Neuropharmacology. 2013 Aug;71:204-15. doi: 10.1016/j.neuropharm.2013.03.021. Epub 2013 Apr 15. Neuropharmacology. 2013. PMID: 23597506
MicroRNA let-7d is a target of cannabinoid CB1 receptor and controls cannabinoid signaling.
Chiarlone A, Börner C, Martín-Gómez L, Jiménez-González A, García-Concejo A, García-Bermejo ML, Lorente M, Blázquez C, García-Taboada E, de Haro A, Martella E, Höllt V, Rodríguez R, Galve-Roperh I, Kraus J, Guzmán M. Chiarlone A, et al. Neuropharmacology. 2016 Sep;108:345-52. doi: 10.1016/j.neuropharm.2016.05.007. Epub 2016 May 11. Neuropharmacology. 2016. PMID: 27179908
Astroglial monoacylglycerol lipase controls mutant huntingtin-induced damage of striatal neurons.
Ruiz-Calvo A, Bajo-Grañeras R, Maroto IB, Zian D, Grabner GF, García-Taboada E, Resel E, Zechner R, Zimmermann R, Ortega-Gutiérrez S, Galve-Roperh I, Bellocchio L, Guzmán M. Ruiz-Calvo A, et al. Among authors: galve roperh i. Neuropharmacology. 2019 May 15;150:134-144. doi: 10.1016/j.neuropharm.2019.03.027. Epub 2019 Mar 23. Neuropharmacology. 2019. PMID: 30914306
Hypothesis: cannabinoid therapy for the treatment of gliomas?
Velasco G, Galve-Roperh I, Sánchez C, Blázquez C, Guzmán M. Velasco G, et al. Neuropharmacology. 2004 Sep;47(3):315-23. doi: 10.1016/j.neuropharm.2004.04.016. Neuropharmacology. 2004. PMID: 15275820 Review.
80 results